Skip Navigation
Skip to contents

J Korean Diabetes.  2019 Sep;20(3):136-141. 10.4093/jkd.2019.20.3.136.

Bariatric/Metabolic Surgery and Type 2 Diabetes

Affiliations
  • 1Department of Endocrinology and Metabolism, Chosun University Hospital, Gwangju, Korea. endocrine@chosun.ac.kr

Abstract

When type 2 diabetes and obesity occur together, disease burden is increased and this is an important public health concern due to the deleterious effects. Despite continuing advances in pharmacological approaches to diabetes, diabetes still remains a chronic, progressive, and irreversible disease. Recently, bariatric surgery, initially developed to treat severe obesity, has attracted growing interest for its beneficial effects on improvement in glucose outcomes and type 2 diabetes remission. Several studies suggest considering this surgery as metabolic surgery because it leads to improvement in obesity-related metabolic comorbidities. The Diabetes Surgery Summit recently recommended inclusion of bariatric surgery among glucose-lowering interventions for type 2 diabetes and obesity. Bariatric surgery can be considered as one effective treatment option and may present an appropriate opportunity to improve prognosis in selected people with type 2 diabetes.

Keyword

Bariatric surgery; Diabetes mellitus, type 2

MeSH Terms

Bariatric Surgery
Comorbidity
Diabetes Mellitus, Type 2
Glucose
Obesity
Obesity, Morbid
Prognosis
Public Health
Glucose
Full Text Links
  • JKD
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2026 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr